Phase I/II study of erlotinib combined with cisplatin and radiotherapy for locally advanced squamous cell carcinoma of the head and neck (SCCHN)

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Clinical Oncology

• Publication date

  2005-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2005.23.16_SUPPL.5596
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Produção nacional de medicamentos antineoplásicos por um laboratório oficial: uma proposta estratégica

  2013cites this paper
• Novel Chemoradiotherapy Regimens Incorporating Targeted Therapies in Locally Advanced Head and Neck Cancers

  2012cites this paper
• Empowering induction therapy for locally advanced head and neck cancer.

  2011cites this paper
• Molecular Determinants of Radiation Response

  2011cites this paper
• EGFR targeting drugs in the treatment of head and neck squamous cell carcinoma

  2010cites this paper
• Molecular targeted therapies in all histologies of head and neck cancers: an update

  2010cites this paper
• Report on the Evidence Regarding Off-Label Indications for Targeted Therapies used in Cancer Treatment

  2010cites this paper
• Targeted therapy for squamous cell carcinoma of the head and neck.

  2009cites this paper
• A multidisciplinary approach to squamous cell carcinomas of the head and neck: an update

  2008cites this paper
• Clinical application of EGFR inhibitors in head and neck squamous cell cancer.

  2008cites this paper
• Incorporation of molecularly targeted agents in the primary treatment of squamous cell carcinomas of the head and neck.

  2008cites this paper
• EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck

  2008cites this paper
• Targeted therapy in head and neck cancer

  2008cites this paper
• Phase I Trial of Erlotinib Combined with Cisplatin and Radiotherapy for Patients with Locally Advanced Cervical Squamous Cell Cancer

  2008cites this paper
• Combination of radiotherapy with EGFR antagonists for head and neck carcinoma

  2007cites this paper
• Targeting the ErbB family in head and neck cancer

  2007cites this paper
• Targeted therapies in head and neck cancer

  2007cites this paper
• Biological agents in head and neck cancer

  2007cites this paper
• Neoadjuvant chemotherapy in head and neck cancer: should it be revisited?

  2007cites this paper
• The role of taxanes and targeted therapies in locally advanced head and neck cancer

  2007cites this paper
• Tumores del área ORL. Tratamiento de quimiorradioterapia

  2007cites this paper
• Locally Advanced Squamous Cell Cancer of the Head and Neck — Targeting Epidermal Growth Factor Receptor

  2007cites this paper
• Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck

  2007cites this paper
• A review of erlotinib and its clinical use

  2006cites this paper
• Cetuximab in the treatment of head and neck cancer

  2006cites this paper
• Epidermal growth factor receptor – targeted molecular therapeutics for head and neck squamous cell carcinoma

  2006cites this paper
• Biological agents in head and neck cancer.

  2006cites this paper
• Targeting epidermal growth factor receptor signaling in the treatment of head and neck cancer

  2006cites this paper
• Targeting receptor tyrosine kinases and their signal transduction routes in head and neck cancer.

  2006cites this paper